The Biopoin market is witnessing steady growth over the forecast period, supported by growth in chronic renal failure cases, expansion of oncology supportive care.
Read More
The Bioclate (Armour) market is witnessing steady growth over the forecast period, supported by growth of personalized hemophilia care, expansion of home infusion programs.
Read More
The Bimzelx market is witnessing steady growth over the forecast period, supported by expanding indications beyond psoriasis, increasing biologic penetration in autoimmune diseases.
Read More
The Beyfortus market is witnessing steady growth over the forecast period, supported by expanding newborn protection programs, increasing rsv awareness.
Read More
The Bexsero market is witnessing steady growth over the forecast period, supported by expansion of adolescent vaccination, increased public health funding.
Read More
The Betaferon Or Betaseron market is witnessing steady growth over the forecast period, supported by aging ms patient population, sustained need for cost effective therapies.
Read More
The Besremi market is witnessing steady growth over the forecast period, supported by rising mpn diagnosis rates, preference for convenient dosing regimens.
Read More
The Besponsa market is witnessing steady growth over the forecast period, supported by growth in hematologic cancer prevalence, expansion of adc pipelines.
Read More
The Berinert market is witnessing steady growth over the forecast period, supported by improved genetic screening for hae, expansion of rare disease centers.
Read More
The Beovu market is witnessing steady growth over the forecast period, supported by aging global population, rising diabetes incidence.
Read More